SAN DIEGO--(BUSINESS WIRE)--Biocom, the Life Science Association of California, announced today the formation of its Los Angeles advisory board with leading experts in business, academia, economic development and professional services. The 11-member advisory board will help guide Biocom’s Los Angeles office in its strategic vision to serve the large and growing life science industry in Los Angeles.
“Each of the accomplished leaders who have joined our board has deep ties to the LA life science industry, and their guidance on our strategic vision will be invaluable as we build on the success of our programs and services already benefiting our members,” said Dina Lozofsky, executive director of Biocom’s downtown Los Angeles office. “In the year and a half since we launched our LA office, our advocacy efforts and support of elected and appointed officials have created a new awareness of the economic impact and high potential of the life science industry in LA.”
Los Angeles County received $893 million in research funding from the National Institutes of Health in fiscal year 2016 and the industry directly or indirectly employs more than 231,000 people from five subsectors, according to Biocom’s 2017 Economic Impact Report.
“The Los Angeles life science industry is in a significant growth phase with particular strength in biopharmaceuticals, medical device, digital health and life science wholesale trade,” said Joe Panetta, president and CEO of Biocom. “As a unifying force for our state, Biocom is uniquely qualified to provide the tools to help California’s life science industry expand. As the largest life science association in the Golden State, we have the deepest bench of experienced talent and a legacy of success that we are excited to bring to bear in Los Angeles.”
The Los Angeles Advisory Board
Bill Allen, CEO, Los Angeles County Economic Development Corporation
Bassil I. Dahiyat, Ph.D., director, president and CEO of Xencor, Inc.
Denise (DeeDee) DeMan, M.S., chairman, and CEO, Bench International
Stephen V. Fiacco, Ph.D., founding member and CEO, EvoRx, Inc.
Scott E. Fraser, Ph.D., Provost Professor and Director of Science Initiatives, University of Southern California
Judith C. Gasson, Ph.D., director of the David Geffen School of Medicine Technology Accelerator
Alice Jacobs, M.D., BioLabs Advisor, Caltech EIR, Third Rock Ventures
Seth Levy, J.D., Los Angeles office managing partner and co-chair of the life sciences group, Nixon Peabody, LLP
Jonathan Thomas, Ph.D., J.D., Chair, governing board, CA Institute for Regenerative Medicine
Martin Zagari, M.D., MBA, vice president of global health economics, Amgen
Joe Panetta, president and CEO, Biocom
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 950 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to its San Diego headquarters, Biocom operates a core office serving the Los Angeles market, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in the San Francisco Bay area and Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.